48 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
in the event that we do not sell an amount of securities sufficient to pursue our business goals described in this prospectus. In addition, because … and adversely affected and we may not be able to achieve our goals, the value of our securities could decline and you could lose some or all of your
8-K
EX-99.1
8reei48t74u5fd0z
26 Jan 22
Processa Pharmaceuticals CEO Dr. David Young Issues Letter to Shareholders Providing Outlook for 2022
8:15am
PRE 14A
2wnv5a2
1 Sep 21
Preliminary proxy
4:46pm